Cargando…

Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular Carcinoma

PURPOSE: Abnormalities in lipid metabolism play a vital role in the development of cancer. This retrospective study aimed to evaluate the survival prognosis of patients with hepatocellular carcinoma (HCC) in terms of (free fatty acid: high-density lipoproteins) ratio (FF-HL) and to compare it with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Ziwei, Liang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427011/ https://www.ncbi.nlm.nih.gov/pubmed/36051861 http://dx.doi.org/10.2147/JHC.S360871

Ejemplares similares

Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma
por: Xiong, Ronghong, et al.
Publicado: (2022)

Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
por: Lin, Qiumei, et al.
Publicado: (2023)

Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2022)

Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection
por: Ni, Xiao-Chun, et al.
Publicado: (2020)

Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
por: Jiang, Jinhua, et al.
Publicado: (2021)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma
por: Gerber, Tiemo Sven, et al.
Publicado: (2023)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
por: Su, Ke, et al.
Publicado: (2023)

Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
por: Pan, Long, et al.
Publicado: (2020)

Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma
por: Li, Lingli, et al.
Publicado: (2021)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction
por: Cui, Zhaolei, et al.
Publicado: (2020)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt
por: Gomaa, Asmaa Ibrahim, et al.
Publicado: (2014)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Xu, Kequan, et al.
Publicado: (2022)

Characterization of a lipid droplet and endoplasmic reticulum stress related gene risk signature to evaluate the clinical and biological value in hepatocellular carcinoma
por: Guo, Ziwei, et al.
Publicado: (2022)

The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2023)

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
por: Yan, Liang, et al.
Publicado: (2020)

Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis
por: Yang, Tingting, et al.
Publicado: (2022)

Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2013)

SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation
por: Yue, Chaosen, et al.
Publicado: (2019)

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
por: Han, Su-xia, et al.
Publicado: (2014)

ULK1: A Promising Biomarker in Predicting Poor Prognosis and Therapeutic Response in Human Nasopharygeal Carcinoma
por: Yun, Miao, et al.
Publicado: (2015)

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma
por: Hussein, Aisha A., et al.
Publicado: (2018)

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
por: Fu, Bidong, et al.
Publicado: (2023)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

Pathway-based biomarker identification with crosstalk analysis for robust prognosis prediction in hepatocellular carcinoma
por: Fa, Botao, et al.
Publicado: (2019)

Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma
por: Bekki, Shigemune, et al.
Publicado: (2020)

Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?
por: Müller, Lukas, et al.
Publicado: (2022)

PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
por: Sun, Yifan, et al.
Publicado: (2019)

Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma
por: Lévi-Strauss, Thomas, et al.
Publicado: (2023)

Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Is a Promising Signature to Predict Prognosis and Therapies for Hepatocellular Carcinoma (HCC)
por: Chen, Yuyan, et al.
Publicado: (2023)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8cbprn2psqkhk52q51kimkr1vb